Aisar Atrakchi

701 total citations
26 papers, 460 citations indexed

About

Aisar Atrakchi is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Aisar Atrakchi has authored 26 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Aisar Atrakchi's work include Carcinogens and Genotoxicity Assessment (10 papers), Water Treatment and Disinfection (5 papers) and Polyamine Metabolism and Applications (4 papers). Aisar Atrakchi is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Water Treatment and Disinfection (5 papers) and Polyamine Metabolism and Applications (4 papers). Aisar Atrakchi collaborates with scholars based in United States, United Kingdom and Germany. Aisar Atrakchi's co-authors include Karen Davis‐Bruno, William B. Weglicki, Marie M. Cassidy, Sarah D. Gray, Richard C. Carlsen, Robert H. Heflich, Benjamin F. Dickens, Sherman Bloom, Nan Mei and Timothy J. McGovern and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Hypertension and American Journal of Physiology-Cell Physiology.

In The Last Decade

Aisar Atrakchi

25 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aisar Atrakchi United States 15 137 92 91 88 58 26 460
Toshiaki Amamoto Japan 14 162 1.2× 77 0.8× 56 0.6× 90 1.0× 28 0.5× 21 578
Dina F. Mansour Egypt 16 169 1.2× 81 0.9× 19 0.2× 113 1.3× 48 0.8× 28 579
Sahar E. El-Swefy Egypt 14 77 0.6× 47 0.5× 40 0.4× 36 0.4× 74 1.3× 25 502
G Czechowska Poland 11 168 1.2× 37 0.4× 46 0.5× 184 2.1× 19 0.3× 32 627
Sarah J. Chapple United Kingdom 12 435 3.2× 78 0.8× 76 0.8× 36 0.4× 44 0.8× 21 839
Pilar Prieto Italy 12 175 1.3× 74 0.8× 32 0.4× 56 0.6× 109 1.9× 15 506
Meral Torun Türkiye 11 197 1.4× 69 0.8× 54 0.6× 20 0.2× 24 0.4× 15 563
M.J. Garle United Kingdom 12 124 0.9× 21 0.2× 43 0.5× 70 0.8× 44 0.8× 24 539
Klarissa D. Hardy United States 6 171 1.2× 66 0.7× 24 0.3× 97 1.1× 30 0.5× 6 446
Barbara Botti Italy 14 185 1.4× 80 0.9× 44 0.5× 73 0.8× 28 0.5× 16 455

Countries citing papers authored by Aisar Atrakchi

Since Specialization
Citations

This map shows the geographic impact of Aisar Atrakchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisar Atrakchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisar Atrakchi more than expected).

Fields of papers citing papers by Aisar Atrakchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisar Atrakchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisar Atrakchi. The network helps show where Aisar Atrakchi may publish in the future.

Co-authorship network of co-authors of Aisar Atrakchi

This figure shows the co-authorship network connecting the top 25 collaborators of Aisar Atrakchi. A scholar is included among the top collaborators of Aisar Atrakchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisar Atrakchi. Aisar Atrakchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Li, Jian Yan, Ying Chen, et al.. (2025). N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA. Chemico-Biological Interactions. 418. 111603–111603. 1 indexed citations
2.
Seo, Ji‐Eun, Aisar Atrakchi, Timothy J. McGovern, et al.. (2025). Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models. Regulatory Toxicology and Pharmacology. 162. 105906–105906. 2 indexed citations
3.
Seo, Ji‐Eun, Xiaobo He, Matthew Bryant, et al.. (2025). Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes. Chemico-Biological Interactions. 416. 111538–111538. 1 indexed citations
4.
Heflich, Robert H., Michelle E. Bishop, Roberta A. Mittelstaedt, et al.. (2024). Optimizing the detection of N-nitrosamine mutagenicity in the Ames test. Regulatory Toxicology and Pharmacology. 153. 105709–105709. 15 indexed citations
5.
Guo, Xiaoqing, Robert T. Dorsam, Aisar Atrakchi, et al.. (2024). Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells. Regulatory Toxicology and Pharmacology. 154. 105730–105730. 9 indexed citations
6.
Li, Xilin, Ji‐Eun Seo, Xiaoqing Guo, et al.. (2023). Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays. Regulatory Toxicology and Pharmacology. 141. 105410–105410. 23 indexed citations
7.
Seo, Ji‐Eun, Xilin Li, Aisar Atrakchi, et al.. (2023). Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models. Archives of Toxicology. 97(10). 2785–2798. 18 indexed citations
8.
He, Xiaobo, Xiaoqing Guo, Matthew Bryant, et al.. (2022). Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s. Archives of Toxicology. 96(11). 3077–3089. 19 indexed citations
9.
Robison, Timothy W., Robert H. Heflich, Mugimane G. Manjanatha, et al.. (2021). Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurity. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 868-869. 503386–503386. 12 indexed citations
10.
Mathis, Mitchell, et al.. (2017). The US Food and Drug Administration’s Perspective on the New Antipsychotic Pimavanserin. The Journal of Clinical Psychiatry. 78(6). e668–e673. 29 indexed citations
11.
Elespuru, Rosalie K., Rajiv Agarwal, Aisar Atrakchi, et al.. (2009). Current and Future Application of Genetic Toxicity Assays: The Role and Value of In Vitro Mammalian Assays. Toxicological Sciences. 109(2). 172–179. 29 indexed citations
12.
Davis‐Bruno, Karen & Aisar Atrakchi. (2006). A Regulatory Perspective on Issues and Approaches in Characterizing Human Metabolites. Chemical Research in Toxicology. 19(12). 1561–1563. 46 indexed citations
13.
Valentin, Jean‐Pierre, Alan Bass, Aisar Atrakchi, Klaus Olejniczak, & Kannosuke Fujimori. (2005). Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A. Journal of Pharmacological and Toxicological Methods. 52(1). 22–29. 12 indexed citations
14.
Wu, Kuei‐Meng, James G. Farrelly, Debra Birnkrant, et al.. (2004). Regulatory Toxicology Perspectives on the Development of Botanical Drug Products in the United States. American Journal of Therapeutics. 11(3). 213–217. 18 indexed citations
15.
Wu, K.M., Aisar Atrakchi, Chao Chen, et al.. (2000). Regulatory science: a special update from the United States Food and Drug Administration. Toxicology Letters. 111(3). 199–202. 14 indexed citations
16.
Atrakchi, Aisar, Sarah D. Gray, & Richard C. Carlsen. (1994). Development of soleus muscles in SHR: relationship of muscle deficits to rise in blood pressure. American Journal of Physiology-Cell Physiology. 267(3). C827–C835. 25 indexed citations
17.
Atrakchi, Aisar, Sherman Bloom, Benjamin F. Dickens, I. Tong Mak, & William B. Weglicki. (1992). Hypomagnesemia and isoproterenol cardiomyopathies: Protection by probucol. Cardiovascular Pathology. 1(2). 155–160. 16 indexed citations
18.
Pickar, Joel G., Aisar Atrakchi, Sarah D. Gray, & Richard C. Carlsen. (1991). Apparent Upregulation of Na+, K+Pump Sites in SHR Skeletal Muscle with Reduced Transport Capacity. Clinical and Experimental Hypertension Part A Theory and Practice. 13(5). 645–652. 5 indexed citations
19.
Atrakchi, Aisar, et al.. (1990). Magnesium deficiency-induced cardiomyopathy: Protection by vitamin E. Biochemical and Biophysical Research Communications. 170(3). 1102–1106. 60 indexed citations
20.
Atrakchi, Aisar, Richard C. Carlsen, Sarah D. Gray, A. Michel, & A J Hance. (1989). Beta-receptor properties in soleus muscles from spontaneously hypertensive rats.. Hypertension. 14(1). 54–60. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Amamoto Breakdown of academic impact, for papers by Dina F. Mansour Breakdown of academic impact, for papers by Sahar E. El-Swefy Breakdown of academic impact, for papers by G Czechowska Breakdown of academic impact, for papers by Sarah J. Chapple Breakdown of academic impact, for papers by Pilar Prieto Breakdown of academic impact, for papers by Meral Torun Breakdown of academic impact, for papers by M.J. Garle Breakdown of academic impact, for papers by Klarissa D. Hardy Breakdown of academic impact, for papers by Barbara Botti
Rankless by CCL
2026